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Abstract 9 
This report describes the first outbreak of methicillin-resistant Staphylococcus aureus 10 
USA 300 in a general hospital ward in Japan, involving six healthcare workers and four 11 
patients. This report emphasizes the need for healthcare personnel to be alert that MRSA 12 





Accumulating evidence indicates that community-associated methicillin resistant 16 
Staphylococcus aureus (CA-MRSA) isolates can readily produce outbreaks in hospitals, 17 
adding to the threat posed by these organisms (1-3).  CA- MRSA is genetically 18 
heterogeneous, and includes a variety of clones such as the multilocus sequence (ST) 1 19 
(USA400) and ST8 (USA300) types that emerged as major clones in the United States.  20 
The USA300 clone can replace preexisting MRSA clones, and it now represents the 21 
predominant CA-MRSA clone in the United States (4,5).  Until now, CA-MRSA 22 
infections reported in Japan have been sporadic, and most strains did not harbor the 23 
Panton-Valentine leukocidin (pvl) genes (6).
 
  24 
In September 2009, we were notified that a cluster of skin infections had broken out 25 
among healthcare workers (HCWs) and hospitalized patients in a general ward.  We 26 
document herein the first outbreak of MRSA harboring pvl genes belonging to the 27 
USA300 clone in a healthcare setting in Japan.
 
28 
At the time of notification, 65 patients were being cared for by 96 HCWs in a general 29 
ward at the tertiary care, 1240-bed Kyoto University Hospital (Japan), where 30 
dermatological disorders were quite prevalent.  We were notified that a cluster of skin 31 
infections had developed among four healthcare workers (HCW 1-4) and it seemed 32 
compatible with S. aureus infection.  Two weeks later, one patient (Patient 4) 33 
developed a skin abscess in the left arm from which MRSA was isolated.  The isolate 34 
was susceptible to erythromycin, clindamycin and gentamicin.  The antimicrobial 35 
susceptibility pattern was distinct from that of healthcare-associated MRSA 36 
(HA-MRSA) strains in Japan, which were usually multidrug-resistant and of which 37 
MIC levels of β-lactams were high.  Subsequently, skin abscesses relapsed on the legs 38 
and chest of HCW 1 and HCW 5 and developed on the legs and buttock of HCW 6.  39 
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Eventually MRSA isolates were recovered from  HCWs. 40 
Based on information derived from these cultures, we developed a case definition in 41 
which MRSA with a specific antibiogram was recovered from a clinical specimen. The 42 
case-defined antibiogram was susceptible to erythromycin, clindamycin and gentamicin, 43 
but resistant to levofloxacin and β-lactams with MIC levels below those of HA-MRSA. 44 
We reviewed the antimicrobial susceptibility profiles of MRSA strains from all adult 45 
and pediatric hospitalized patients who were under care at Kyoto University Hospital 46 
during 2009 to detect any unidentified MRSA.  HCWs were screened in the ward 47 
using nasal swabs to identify MRSA carriers.  48 
Clinical specimens were inoculated onto mannitol salt agar plates and examined after 49 
48h.  Susceptibility testing proceeded according to the Clinical and Laboratory 50 
Standards Institute.  The mecA gene, PVL determinants and arcA gene on the arginine 51 
catabolite mobile element (ACME) were detected and SCCmec typing was performed 52 
by PCR (7-9).  The typing procedure included PFGE using the restriction enzyme 53 
SmaI as described (5).  Multilocus sequence typing proceeded as described and the 54 
nomenclature was specified as previously described. (www.MLST.net) 55 
Patients 1 to 3 who became infected with MRSA were newly identified based on the 56 
antimicrobial susceptibility profile described in the case definition (Table 1).  A review 57 
of the medical records revealed that the first MRSA infection occurred in March 2009.  58 
Patient 1 developed catheter-related bloodstream infection followed by pneumonia and 59 
required intravenous anti-MRSA drug administration.  Six of nine skin and soft tissue 60 
infections (skin abscesses, folliculitis) were treated with antibiotics, whereas three were 61 
cured by drainage alone.  Patient 1 as well as HCW 1 and 5 developed recurrent 62 
infections.  No case patient had a history of visiting abroad recently.  All MRSA 63 
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isolates recovered from the case patients contained SCC mec type IV, the pvl gene and 64 
ACME-associated arcA gene.  PFGE-based findings identified all isolates as being 65 
identical to and indistinguishable from the USA 300 clone.  MLST defined all of them 66 
as ST8. 67 
Excluding the isolates recovered from the case patients, four of 825 strains of MRSA 68 
isolates at our institution in 2009 had the same antimicrobial susceptibility profile as the 69 
outbreak strain.  Those isolates were recovered from swab specimens and the patients 70 
did not have a symptom of infection when the specimens were taken.  Screening nasal 71 
swabs of HCWs did not identify any carriers of CA-MRSA USA 300 other than the case 72 
patients.  73 
Discussion 74 
To our knowledge, this is the first report to document an outbreak of 75 
healthcare-associated and -transmitted CA-MRSA USA300 in Japan.  To date, 76 
outbreaks of PVL-positive CA-MRSA have been reported, especially in neonatal 77 
intensive care units and long term care facilities in the United states and European 78 
countries (1-3).  However, no outbreaks of CA-MRSA in either community- or 79 
nosocomial settings in Japan have been described.  Only one sporadic infection with 80 
the USA300 clone in Japan has been documented (10).  We speculate that infected 81 
HCWs or unidentified PVL-positive MRSA carriers served as the source of infection for 82 
Patients 1 to 4, because all of them became infected while in hospital.  In addition, we 83 
considered that the causative agent was community-associated because antibiograms of 84 
the outbreak strain were distinct from those of HA-MRSA strains.  This was supported 85 
by a review of the antibiotic susceptibility of MRSA strains isolated at our institution 86 
during 2009; the case-defined antibiogram occurred in only 0.5% of isolates.   87 
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The findings of this investigation have considerable public health implications. 88 
Although HA-MRSA remains a serious threat to hospitalized patients, the introduction 89 
of CA-MRSA strains into tertiary care hospitals like our hospital represents an 90 
especially serious challenge.  Many of the infections caused by these strains have been 91 
reported to cause serious infections among healthy adults and can be severer and more 92 
life-threatening to those who are highly immunocompromised.  In this study, healthy 93 
HCWs suffered from skin abscesses, although most infections were mild and cured 94 
without parenteral anti-MRSA drugs.  Considering that infection relapsed in some case 95 
patients, further investigations are needed to establish the management of PVL-positive 96 
MRSA carriers, especially when they are caregivers.  Systematic studies involving 97 
healthcare settings are needed to reveal the transmission of such CA-MRSA isolates 98 
within the healthcare system.  These would provide not only an accurate estimate of 99 
CA-MRSA prevalence, but would help monitor the emergence of more resistant and/or 100 
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Table 1 Characteristics of patients with CA-MRSA infections and their treatment, Kyoto 146 






















8/27 Pneumonia Lung LZD None 






Thigh GEN Spontaneous 
Pt 3 42,M 
Polyarteritis 
nodosa 
10/19 Folliculitis Legs ST Spontaneous 

















Arm CLI None 
HCW 
2 
27,F none 9/21 
Skin 
abscess 
Arm GEN Surgical 
HCW 
3 
27,F none 9/21 
Skin 
abscess 
Leg MINO Surgical 
HCW 
4 
25,F none 9/21 
Skin 
abscess 
















31,M none 11/24 
Skin 
abscess 
Thigh CLI Spontaneous 
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TEIC, teicoplanin; LZD, linezolid; GEN, gentamicin(topical); ST, 148 
Trimethoprim-sulfamethoxazole; MINO, minocyclin; CLI, clindamycin; MUP, 149 
mupirocin (topical), CRBSI; catheter-related bloodstream infection150 
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